MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsHighNegative
Announced Tue, 17 Mar · 16:12 IST

Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest

Regulatory & Legal View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.0%1-day move
₹30.78
prior close
₹30.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.3+3.3+4.6+4.5-0.0-0.3-5.1-4.9-3.2-12.1-0.2-4.8-1.2-3.1
Up moveDown movePending
AI summary

Mangalam Drugs and Organics has disclosed to the stock exchanges that it has defaulted on its loan obligations to two banks for over 30 days. The company owes Rs. 979.21 lakhs to Bank of Maharashtra (cash credit account, default started 17 October 2025) and Rs. 606.08 lakhs to Bank of Baroda (default started 20 October 2025), taking total overdue amount to roughly Rs. 15.85 crores as on 15 March 2026. The company has stated that it is making arrangements to pay the overdue amounts as soon as possible. The disclosure was made under SEBI's Listing Obligations and Disclosure Requirements Regulations, which require listed companies to immediately inform exchanges about any loan default.

Likely market impact

This is a negative signal for shareholders — the company is struggling to service its debt and has been in continuous default for nearly five months, which raises concerns about its liquidity and financial health. Such defaults can trigger penalties, higher borrowing costs, and potential action by lenders, which may put further pressure on the stock price.